We are live on ! Find out more
TCBPW

TC BioPharm (Holdings) plc Warrants
TCBPW

Delisted

TCBPW was delisted on the 21st of March, 2025.

Back to rankings

7 hedge funds and large institutions have $3.17M invested in TC BioPharm (Holdings) plc Warrants in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EAM
Empery Asset Management
New York
+$1.31M
2
AC
Armistice Capital
New York
+$875K
3
ACM
Altium Capital Management
New York
+$438K
4
KC
Kepos Capital
New York
+$219K
5
NCM
Nantahala Capital Management
Connecticut
+$109K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Empery Asset Management
New York
$1.38M +$1.31M +2,823,528 New
AC
2
Armistice Capital
New York
$922K +$875K +1,882,352 New
ACM
3
Altium Capital Management
New York
$461K +$438K +941,176 New
KC
4
Kepos Capital
New York
$231K +$219K +470,588 New
NCM
5
Nantahala Capital Management
Connecticut
$117K +$109K +235,294 New
WAM
6
Warberg Asset Management
Illinois
$44K +$41K +88,267 New
VF
7
Virtu Financial
New York
$8K +$7.33K +15,775 New

TCBPW Hedge Fund Activity: Q1 2022 in Review

7 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q1 2022, worth a combined $3.17M.

Buyers outnumbered sellers: 7 funds opened new TCBPW positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Empery Asset Management, opening a new position worth an estimated $1.31M.

  • 7 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q1 2022, up from 0 in Q4 2021.
  • Funds reported $3.17M of TC BioPharm (Holdings) plc Warrants stock for Q1 2022.
  • 7 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q1 2022 and 0 closed out, a net change of +7 holders.
  • The largest TC BioPharm (Holdings) plc Warrants buyer in Q1 2022 was Empery Asset Management, an estimated $1.31M added.

Based on aggregated 13F filings for Q1 2022.